COMMUNIQUÉS West-GlobeNewswire

RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024
24/10/2024
ALISO VIEJO, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced [...]
IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st
24/10/2024
WINTER SPRINGS, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 third quarter financial results before the market opens on Thursday, [...]
TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
24/10/2024
MALVERN, Pa., Oct. 24, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction, today announced the closing of its [...]
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025
24/10/2024
Year-over-year revenue grows 11% , operating profit up 34% , non-GAAP operating profit up 27% Operating cash flow of $326 million Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at [...]
Ardelyx Shares Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) at the American Society of Nephrology’s Kidney Week
24/10/2024
WALTHAM, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet [...]
Teknova to Report Third Quarter 2024 Financial Results on November 7, 2024
24/10/2024
HOLLISTER, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, [...]
Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies
24/10/2024
Strengthens Lyell’s clinical pipeline with the addition of IMPT-314, a dual-targeting CD19/CD20 CAR T-cell product candidate Data from ImmPACT’s multi-center Phase 1-2 clinical trial of IMPT-314 in patients with large B [...]
INmune Bio Inc. Announces Publication in Cell Reports Demonstrating XPro™ Promotes Remyelination
24/10/2024
Data from Animal Model Study Demonstrate XPro™ converts m icroglia from a demyelinating cell to a remyelinating cell Multi-year study published has implications for many CNS diseases including Alzheimer’s Boca Raton, [...]
Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds
24/10/2024
WORCESTER, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell [...]
Un chirurgien saoudien récompensé pour avoir réalisé la première transplantation cardiaque robotisée au monde
24/10/2024
« Intervention chirurgicale cardiaque robotisée » au KFSHRC...Un parcours de réussite à la fois pionnier et en pleine accélération RIYAD, Arabie saoudite, 24 oct. 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist [...]
Inozyme Pharma Announces Positive Interim Data from Phase 1 SEAPORT 1 Trial of INZ-701
24/10/2024
- INZ-701 was well-tolerated and significantly increased plasma pyrophosphate (PPi) levels in patients with end-stage kidney disease (ESKD) undergoing hemodialysis; low PPi levels are associated with calciphylaxis, a [...]
Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule
24/10/2024
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 24 OCTOBER 2024 at 19.50 EEST Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule Orion [...]
CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push
24/10/2024
With the potential for explosive profits in a $70 billion industry, CBDL's innovative product line and strategic market positioning stand ready to deliver unparalleled returns for shareholders, making this a true game [...]
Raw Garden Launches Live Resin Sauce Cartridges: Award-Winning Live Resin in a Convenient Ceramic Cartridge
24/10/2024
Experience the full spectrum effects and flavor of dabbable live resin in an easy-to-use, on-the-go cartridge SANTA BARBARA, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Raw Garden, the #1 concentrates brand in California [...]
ORYZON Reports Financial Results and Corporate Update for Quarter Ended September 30, 2024
24/10/2024
Final data from PORTICO, global Phase IIb vafidemstat trial in BPD, presented at the 37th ECNP annual conference in September Company moving forward with PORTICO-2 Phase III trial preparations following positive [...]
Eurobio Scientific : ouverture de l’offre publique d’achat jusqu’au 27 novembre
24/10/2024
Eurobio Scientific : ouverture de l’offre publique d’achat jusqu’au 27 novembre Paris, le 24 octobre 2024 – 18h00 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic [...]
GUERBET : Chiffre d’affaires au 30 septembre 2024.
24/10/2024
Chiffre d’affaires au 30 septembre 2024 Maintien de la dynamique de croissance Chiffre d’affaires à 9 mois : 620,5 M€, en hausse de 9,6% à TCC 1 Au troisième trimestre, la dynamique est restée soutenue (+5,4% à TCC), [...]
GUERBET : Revenue at September 30, 2024.
24/10/2024
Revenue at September 30, 2024 Continued growth momentum 9-month revenue: €620.5m, up 9.6% at CER 1 In the third quarter, momentum remained strong (+5.4% at CER), driven by the Americas (+13.1%) and Asia (+8.1%), while [...]
ONWARD® Medical Publishes Prospectus for Listing of New Shares
24/10/2024
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, the Netherlands, Oct. 24, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. ( [...]

Pages